| Literature DB >> 34070604 |
Gayeong Won1, Soo-Im Choi1, Chang-Ho Kang2, Gun-Hee Kim3.
Abstract
The purpose of this study was to evaluate the capacity of Lactiplantibacillus plantarum cal">MG4296 (cal">pan class="Chemical">MG4296) and Lacticaseibacillus paracasei MG5012 (MG5012) on insulin resistance (IR) and diabetes-related metabolic changes in palmitic acid (PA)-induced HepG2 cells and high-fat diet-induced mice. In vitro, cell-free extracts of MG4296 and MG5012 alleviated IR by increasing glucose uptake and glycogen content in PA-induced insulin-resistant HepG2 cells. In vivo, MG4296 and MG5012 supplementation markedly decreased body weight and glucose tolerance. Administration of both strains also improved serum glucose, glycated hemoglobin, insulin, triglyceride, LDL/HDL ratio, and homeostatic model assessment of IR (HOMA-IR). Histopathological analysis of liver tissue demonstrated a significant reduction in lipid accumulation and glycogen content. Moreover, MG4296 and MG5012 treatment enhanced phosphoinositide-3 kinase (PI3K)/protein kinase B (Akt) expression in the liver. Overall, MG4296 and MG5012 could prevent HFD-induced glucose tolerance and hyperglycemia by improving IR. Therefore, L. plantarum MG4296 and L. paracasei MG5012 could be useful as new probiotics candidates to improve T2DM.Entities:
Keywords: Lacticaseibacillus paracasei MG5012; Lactiplantibacillus plantarum MG4296; PI3K/Akt; diabetes; insulin resistance
Year: 2021 PMID: 34070604 PMCID: PMC8228052 DOI: 10.3390/microorganisms9061139
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Effect of MG4296 and MG5012 on (A) cell viability, (B) glucose uptake, and (C) glycogen contents in insulin resistant-induced HepG2 cells by palmitic acid. Data are presented as mean ± SD (n = 3). ** p < 0.01, *** p < 0.001 vs. CON cells, and # p < 0.05, ### p < 0.001 vs. PA-treated cells.
Figure 2Effect of MG4296 and MG5012 on (A) body weight gain, (B) total weight gain, (C) liver weight, and (D) adipose tissue weight in HFD-induced T2DM mice. Mice were fed with ND or HFD for 12 weeks. HFD-fed mice were treated with an experimental vehicle or both strains. Body weight was measured weekly. Data are presented as mean ± SD (n = 6). ### p < 0.001 vs. ND group. ** p < 0.01, *** p < 0.001 vs. HFD group. ND; normal diet, HFD; high-fat diet.
Figure 3Effect of MG4296 and MG5012 on (A) oral glucose tolerance test (OGTT), (B) area under the curve (AUC), (C) fasting glucose, (D) fasting insulin, and (E) homeostatic model assessment of insulin resistance (HOMA-IR) in HFD-induced T2DM mice. Data are presented as mean ± SD (n = 6). ### p < 0.001 vs. ND group. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. HFD group. HFD group. ND; normal diet, HFD; high-fat diet.
Figure 4Biochemical profile of serum in HFD-induced T2DM mice. (A) AST, (B) ALT, (C) TG, (D) HbA1c, (E) TC, and (F) LDL/HDL ratio. Data are presented as mean ± SD (n = 6). # p < 0.05, ### p < 0.001 vs. ND group. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. HFD group. ND; normal diet, HFD; high-fat diet.
Figure 5Histological changes in liver tissue of HFD-induced T2DM mice. (A) Representative photographs of hematoxylin and eosin (H&E)-stained sections of liver tissues (40× and 100× magnification), (B) Hepatic steatosis score, (C) Glycogen content, (D) Triglyceride (TG) content. Results are presented as mean ± SD (n = 6). # p < 0.05, ### p < 0.001 vs. ND group. * p < 0.05, ** p < 0.01 vs. HFD group. ND; normal diet, HFD; high-fat diet.
Figure 6Effects of MG4296 and MG5012 on the IRS-1/PI3K/Akt protein expression in liver tissue of HFD-induced T2DM mice. (A) Representative western blot, (B) p-IRS-1/IRS-1, (C) p-PI3K/PI3K, and (D) p-Akt/Akt. Data are presented as mean ± SD (n = 3). ### p < 0.001 vs. ND group. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. HFD group. ND; normal diet, HFD; high-fat diet.